Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
4h agoMedline Industries files for U.S. IPO, potential valuation near US$50 billion
Medline Industries, one of the world’s larger medical-supplies manufacturers, disclosed that its revenue rose 9.7% in H1-2025 and announced plans for a U.S. initial public offering, which could value the company around US$50 billion. The filing comes as the IPO market revives after years of sluggish listings, and reflects investor appetite for large-cap industrials with steady cash flows. The company is backed by private-equity and aims to leverage the public markets to fund growth, acquisitions and global expansion of medical-device and supply-chain operations.
Explore:Mutual Fund Categories
positive
4h agoMedline Industries files for U.S. IPO, potential valuation near US$50 billion
Medline Industries, one of the world’s larger medical-supplies manufacturers, disclosed that its revenue rose 9.7% in H1-2025 and announced plans for a U.S. initial public offering, which could value the company around US$50 billion. The filing comes as the IPO market revives after years of sluggish listings, and reflects investor appetite for large-cap industrials with steady cash flows. The company is backed by private-equity and aims to leverage the public markets to fund growth, acquisitions and global expansion of medical-device and supply-chain operations.
Explore:Mutual Fund Categories
Breaking
positive
Medline Industries files for U.S. IPO, potential valuation near US$50 billion
about 5 hours ago
1 min read
83 words
Medline Industries files for US IPO with potential valuation close to US$50 billion, tapping the revival in large-cap listings.
Medline Industries, one of the world’s larger medical-supplies manufacturers, disclosed that its revenue rose 9.7% in H1-2025 and announced plans for a U.S. initial public offering, which could value the company around US$50 billion. The filing comes as the IPO market revives after years of sluggish listings, and reflects investor appetite for large-cap industrials with steady cash flows. The company is backed by private-equity and aims to leverage the public markets to fund growth, acquisitions and global expansion of medical-device and supply-chain operations.
Medline Industries, one of the world’s larger medical-supplies manufacturers, disclosed that its revenue rose 9.7% in H1-2025 and announced plans for a U.S. initial public offering, which could value the company around US$50 billion. The filing comes as the IPO market revives after years of sluggish listings, and reflects investor appetite for large-cap industrials with steady cash flows. The company is backed by private-equity and aims to leverage the public markets to fund growth, acquisitions and global expansion of medical-device and supply-chain operations.
Tags:
ipo
stocks
ipo
stocks
global
healthcare
Oct 31, 2025 • 22:11 IST